# Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

> **NCT06140875** · NA · RECRUITING · sponsor: **Charite University, Berlin, Germany** · enrollment: 26 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** Radiofrequency electromagnetic field treatment

## Key facts

- **NCT ID:** NCT06140875
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-15
- **Primary completion:** 2029-05-14
- **Final completion:** 2029-05-14
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06140875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06140875, "Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06140875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*